The impact of epidermal-growth-factor-receptor mutations in response to lung-cancer therapy

被引：0
|
作者：
Jonathan E Dowell
John D Minna
机构：
[1] University of Texas Southwestern Medical Center,Director of Hamon Center for Therapeutic Oncology Research and a Professor in the Departments of Internal Medicine and Pharmacology
[2] Chief of Hematology and Oncology at the Dallas Veterans Affairs Medical Center,undefined
来源：
Nature Clinical Practice Oncology | 2004年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Non-small-cell lung cancer is the leading cause of cancer death in the US despite advances in therapy. The epidermal-growth-factor receptor has been investigated as a target for therapy using EGFR-specific tyrosine kinase inhibitors. This Viewpoint discusses the implications of the correlation of positive responses seen in patients harboringEGFRmutations.
引用
收藏
页码：2 / 3
页数：1
相关论文
共 50 条
  • [31] Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
    Lee, Kyung-Hun
    Han, Sae-Won
    Hwang, Pil Gyu
    Oh, Do-Youn
    Kim, Dong-Wan
    Chung, Doo Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (06) : 344 - 350
  • [32] EPIDERMAL-GROWTH-FACTOR-RECEPTOR EXPRESSION IS ASSOCIATED WITH RAPID TUMOR PROLIFERATION IN BLADDER-CANCER
    SAUTER, G
    HALEY, J
    CHEW, K
    KERSCHMANN, R
    MOORE, D
    CARROLL, P
    MOCH, H
    GUDAT, F
    MIHATSCH, MJ
    WALDMAN, F
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (04) : 508 - 514
  • [33] Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer A Brief Report
    Shiao, Tsu-Hui
    Chang, Yih-Leong
    Yu, Chong-Jen
    Chang, Yeun-Chung
    Hsu, Ya-Chieh
    Chang, Shih-Han
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 195 - 198
  • [34] Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
    Jorge, S. E. D. C.
    Kobayashi, S. S.
    Costa, D. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (11) : 929 - 939
  • [35] Mutations of the epidermal growth factor receptor gene in lung cancer:: Biological and clinical implications
    Kosaka, T
    Yatabe, Y
    Endoh, H
    Kuwano, H
    Takahashi, T
    Mitsudomi, T
    CANCER RESEARCH, 2004, 64 (24) : 8919 - 8923
  • [36] Differential response of non-small cell lung cancer harboring different epidermal growth factor receptor mutations to ablative radiation therapy
    Al Rabea, Areej
    Meehan, Brian
    Daniel, Paul
    Sabri, Siham
    Nirodi, Chaitanya
    Rak, Janusz
    Abdulkarim, Bassam
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    CANCER SCIENCE, 2007, 98 (12) : 1817 - 1824
  • [38] Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
    Wu, Shang-Gin
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Lee, Jih-Hsiang
    Hsu, Ya-Chieh
    Chang, Yih-Leong
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    LUNG CANCER, 2011, 72 (03) : 333 - 339
  • [39] Epidermal growth factor receptor (EGFR)-activating mutations (mut) and response to gefitinib in lung adenocarcinomas
    Moran, T
    de Castellanos, D
    Gomez, C
    Valero, P
    Alberola, V
    Gonzalez-Larriba, J
    Massuti, B
    Maestu, I
    Izquierdo, A
    Queralt, C
    LUNG CANCER, 2005, 49 : S110 - S110
  • [40] The biology of epidermal growth factor receptor in lung cancer
    Scagliotti, GV
    Selvaggi, G
    Novello, S
    Hirsch, FR
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 4227S - 4232S
12345